News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Amgen (AMGN) to Pay $25 Million to Settle Kickback Allegations


4/17/2013 8:19:21 AM

Amgen Inc has agreed to pay $24.9 million to settle allegations that it provided kickbacks to long-term care pharmacy providers to entice them to use its Aranesp anemia drug instead of a rival medicine, the Department of Justice announced on Tuesday. The DOJ charged that the world's largest biotechnology company violated the False Claims Act through kickbacks paid to Omnicare Inc, Kindred Healthcare Inc and PharMerica Corp in exchange for switching Medicare and Medicaid patients to Aranesp to treat their anemia. "We will continue to pursue pharmaceutical companies that pay kickbacks to long-term care pharmacy providers to influence drug-prescribing decisions," Stuart Delery, acting assistant attorney general for the Justice Department's Civil Division, said in a statement. "Patients in skilled nursing facilities deserve care that is free of improper financial influences," he added.

Read at Reuters
Read at Fox News
Read at Manufacturing
Read at Los Angeles Times
Read at Wall Street Journal

comments powered by Disqus
Amgen
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES